Antagonist Protocol
GnRH Antagonist Protocol: Is It Optimal for All Patients of Different Ages Undergoing In Vitro Fertilization and Embryo Transfer?
... GnRH-ant protocol group and GnRH-a long protocol group, and then every group were subdivided into four age ...GnRH-ant protocol, which was significantly lower than another ( P < ...GnRH-ant ...
8
Outcome of cryopreserved-thawed embryo transfer in the GnRH agonist versus antagonist protocol
... GnRH antagonist for COS in infertile patients as the decrease of pregnancy rate in cycles using GnRH antagonist protocol was reported (5, ...following antagonist protocol may be due to ...
6
ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial
... GnRH antagonist protocol lead to decreased egg quality, lower implantation, and increased miscarriage rates, so it seems that add- ing GnRH antagonist in early follicular phase in GnRH ...
7
Ectopic pregnancy risk factors for ART patients undergoing the GnRH antagonist protocol: a retrospective study
... During the study period 840 women underwent 1455 antagonist protocol cycles where at least one fresh em- bryo was transferred (Table 1). The pregnancy rate among those triggered with GnRH agonist was 26 % ...
8
GnRH Antagonist Protocol: Is It Effective for Expected Poor Ovarian Responders with Tubal Factor Undergoing IVF?
... optimal protocol for POR is still unknown ...GnRH antagonist protocol in expected poor ovarian ...GnRH-ant protocol, which limited its wide application ...GnRHa protocol was superior to ...
7
Pregnancy outcome of “delayed start” GnRH antagonist protocol versus GnRH antagonist protocol in poor responders: A clinical trial study
... GnRH antagonist protocol administered estrogen priming followed by early follicular-phase GnRH antagonist treatment for 7 days before ovarian stimulation with ...
8
Gonadotropin-Releasing Hormone (GnRH) Agonist Trigger in a GnRH Antagonist Protocol and Severe Ovarian Hyperstimulation Syndrome
... GnRH antagonist protocol, with 225 IU of recombinant FSH (rFSH; Gonal-F; Merck, Darmstadt, ...GnRH antagonist (Cetrotide; Merck) was introduced from day 5 of ...
5
Original Article Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles
... and antagonist protocol are effective in suppressing the incidence of premature luteinizing hormone (LH) surges through reversibly blocking the secretion of pituitary gonadotropins, the exact impact of ...
8
Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial
... OCP/GnRH-antagonist protocol and reported that LZ-treated patients had significantly higher levels of follicular fluid testosterone, androstenedione, and more oocytes retrieved and a higher IR, despite ...
8
Higher endometrial receptivity caused by Letrozole in antagonist protocol-stimulated mouse uterus
... + antagonist and antagonist protocol (alone) of ovarian stimulation conducted in our study were to know the expression of integ- rin β3, E-cadherin in endometrial cell and uterine LIF concentration ...
10
Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles
... and antagonist protocols ...GnRH antagonist protocol, in the current analyses, increased LH and BMI [16] were not identified as predictors of high ovarian response ...
7
A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation
... administration, higher number of MII oocytes and proportion of MII oocytes per number of oocytes retrieved, with the consequent significantly increased number of top-quality embryos, as compared to the hCG-only trigger ...
6
GnRH Agonist and GnRH Antagonist in Intracytoplasmic Injection Cycles
... agonistic protocol for controlled ovarian hyperstimulation (COH) is effective and used most often, thus is considered the gold ...and antagonist in a retrospective study of IVF/ICSI carried out in a ...
5
Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes
... Under informed consent, a total of 278 women were included. They were among those undergoing controlled ovarian hyperstimulation with a GnRH agonist or a GnRH antagonist protocol for an infertility ...
10
EFFECT OF AGE AND DURATION OF INFERTILITY ON LEVELS OF INTERLEUKIN 18 AND CORRELATION TO PREGNANCY RATE FOR WOMEN UNDERGOING ICSI PROGRAM
... Polycystic Ovarian Syndrome (PCOS) is considered as a complex and heterogeneous disorder affecting about 5% to 10% of women ages between 18 and 44 years. [1, 2] It is a well recognized cause of infertility [3] , which ...
8
New algorithm for OHSS prevention
... GnRH antagonist protocol and requires modified luteal support in order to be as efficient as hCG trigger- ing ...the protocol of choice in oocyte donation cycles ...
5
Comparison Pregnancy Outcomes Between Minimal Stimulation Protocol and Conventional GnRH Antagonist Protocols in Poor Ovarian Responders
... stimulation protocol has the following advantages: cost effectiveness, shorter duration of stimulation, reduced gonadotropin requirements and patient-friendly method (3, ...stimulation protocol with others ...
7
Original Article Larger leading follicle size on GnRH antagonist initiation day is associated with higher pregnancy rate in a flexible protocol for IVF/ICSI patients
... (GnRH) antagonist protocol has been used in controlled ovarian hyper-stimulation (COH) for several years, but it is still unknown when the appropriate timing for antagonist admin- istration ...GnRH ...
8
HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics That Are Corrected in the Presence of Drug
... Identification of clinical CCR5 antagonist resistance. We previ- ously reported VCV resistance of an HIV-1 subtype C virus from a VCV-treated participant in ACTG A5211 (Sub07, previously referred to as subject ...
10
A Protein Antagonist of Activation Induced Cytidine Deaminase Encoded by a Complex Mouse Retrovirus
... an antagonist of Apobec enzymes and whether the decreased proviral load in MMTV-SD-induced tumors relative to that of MMTV-WT-induced tumors was the result of Apobec-mediated ...
21